BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borysenko CW, García-palacios V, Griswold RD, Li Y, Iyer AKV, Yaroslavskiy BB, Sharrow AC, Blair HC. Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions. J Cell Physiol 2006;209:1021-8. [DOI: 10.1002/jcp.20812] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Xu W, Li R, Huang A. Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review. Front Immunol 2022;13:891328. [DOI: 10.3389/fimmu.2022.891328] [Reference Citation Analysis]
2 Merimi M, Lagneaux L, Lombard CA, Agha DM, Bron D, Lewalle P, Meuleman N, Najimi M, Sokal EM, Najar M. Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules. Inflamm Res 2021;70:229-39. [PMID: 33404674 DOI: 10.1007/s00011-020-01428-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Jäckle K, Zeis T, Schaeren-Wiemers N, Junker A, van der Meer F, Kramann N, Stadelmann C, Brück W. Molecular signature of slowly expanding lesions in progressive multiple sclerosis. Brain 2020;143:2073-88. [PMID: 32577755 DOI: 10.1093/brain/awaa158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
4 Li J, Wang L, Tian J, Zhou Z, Li J, Yang H. Nongenetic engineering strategies for regulating receptor oligomerization in living cells. Chem Soc Rev 2020;49:1545-68. [DOI: 10.1039/c9cs00473d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
5 Collins FL, Stone MD, Turton J, McCabe LR, Wang ECY, Williams AS. Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels. BMC Musculoskelet Disord 2019;20:326. [PMID: 31299941 DOI: 10.1186/s12891-019-2704-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Lai EH, Yang CN, Lin SK, Wang HW, Kok SH, Hong CY, Su IH, Yang H, Chang JZ. Metformin Ameliorates Periapical Lesions through Suppression of Hypoxia-induced Apoptosis of Osteoblasts. J Endod 2018;44:1817-25. [PMID: 30293696 DOI: 10.1016/j.joen.2018.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Williams A, Wang EC, Thurner L, Liu CJ. Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling. Arthritis Rheumatol 2016;68:2845-56. [PMID: 27428882 DOI: 10.1002/art.39816] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
8 Xu L, Cao Y. Native musk and synthetic musk ketone strongly induced the growth repression and the apoptosis of cancer cells. BMC Complement Altern Med 2016;16:511. [PMID: 27931220 DOI: 10.1186/s12906-016-1493-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
9 Perks WV, Singh RK, Jones GW, Twohig JP, Williams AS, Humphreys IR, Taylor PR, Jones SA, Wang ECY. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease. Am J Pathol 2016;186:2813-23. [PMID: 27664471 DOI: 10.1016/j.ajpath.2016.07.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
10 Solntsev LA, Starikova VD, Sakharnov NA, Knyazev DI, Utkin OV. Strategy of probe selection for studying mRNAs that participate in receptor-mediated apoptosis signaling. Mol Biol 2015;49:457-65. [DOI: 10.1134/s0026893315030164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Collins FL, Williams JO, Bloom AC, Stone MD, Choy E, Wang EC, Williams AS. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. J Immunol Res 2015;2015:901679. [PMID: 26065008 DOI: 10.1155/2015/901679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang EC, Newton Z, Hayward OA, Clark SR, Collins F, Perks WV, Singh RK, Twohig JP, Williams AS. Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3. Arthritis Rheumatol 2014;66:2762-72. [PMID: 25044706 DOI: 10.1002/art.38770] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
13 Utkin OV, Starikova VD, Perenkov AD, Yanchenko OS, Baryshnikov AY, Novikov VV. DR3/LARD spliced mRNA variants’ frequency in colorectal cancer. Mol Biol 2013;47:721-6. [DOI: 10.1134/s0026893313050208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Sessler T, Healy S, Samali A, Szegezdi E. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling. Pharmacol Ther. 2013;140:186-199. [PMID: 23845861 DOI: 10.1016/j.pharmthera.2013.06.009] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 7.6] [Reference Citation Analysis]
15 Celay J, Blanco I, Lázcoz P, Rotinen M, Castresana JS, Encío I. Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment. PLoS One 2013;8:e62771. [PMID: 23650528 DOI: 10.1371/journal.pone.0062771] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
16 Wang EC. On death receptor 3 and its ligands…. Immunology 2012;137:114-6. [PMID: 22612445 DOI: 10.1111/j.1365-2567.2012.03606.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
17 Jones GW, Stumhofer JS, Foster T, Twohig JP, Hertzog P, Topley N, Williams AS, Hunter CA, Jenkins BJ, Wang EC, Jones SA. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J 2011;25:409-19. [PMID: 20826539 DOI: 10.1096/fj.10-166843] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
18 Twohig JP, Roberts MI, Gavalda N, Rees-Taylor EL, Giralt A, Adams D, Brooks SP, Bull MJ, Calder CJ, Cuff S, Yong AA, Alberch J, Davies A, Dunnett SB, Tolkovsky AM, Wang EC. Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3. J Neurosci 2010;30:3782-92. [PMID: 20220013 DOI: 10.1523/JNEUROSCI.1928-09.2010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
19 Bull MJ, Williams AS, Mecklenburgh Z, Calder CJ, Twohig JP, Elford C, Evans BA, Rowley TF, Slebioda TJ, Taraban VY, Al-Shamkhani A, Wang EC. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 2008;205:2457-64. [PMID: 18824582 DOI: 10.1084/jem.20072378] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
20 Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 2008;7:411-25. [PMID: 18404150 DOI: 10.1038/nrd2488] [Cited by in Crossref: 393] [Cited by in F6Publishing: 413] [Article Influence: 26.2] [Reference Citation Analysis]
21 Sharrow AC, Li Y, Micsenyi A, Griswold RD, Wells A, Monga SS, Blair HC. Modulation of osteoblast gap junction connectivity by serum, TNFalpha, and TRAIL. Exp Cell Res 2008;314:297-308. [PMID: 18022159 DOI: 10.1016/j.yexcr.2007.10.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]